Evidence map›Paper›PMID 36834537›Full record

ReviewInternational journal of molecular sciences2023

Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance.

Stefano Martini, Alessandra Gemma, Marco Ferrari, Marco Cosentino, Franca Marino

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. The neuroimmune-glutamate hypothesis of addiction.Neuroscience and biobehavioral reviews · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Research and Clinical Practice Involving the Use ofPharmaceuticals (Basel, Switzerland) · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Polypharmacological Effects of Cannabidiol.Molecules (Basel, Switzerland) · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Stefano MartiniCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.ORCID 0000-0002-2519-9138
Alessandra GemmaCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.
Marco FerrariCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.ORCID 0000-0002-2986-1272
Marco CosentinoCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.ORCID 0000-0002-6978-7775
Franca MarinoCenter for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.
University of Insubria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cannabidiol (CBD) is the main non-psychotropic cannabinoid derived from cannabis (

Indexed as

CannabidiolCannabisCOVID-19AnimalsClinical RelevanceGuinea PigsHumansImmunity, InnateInflammationMiceRatsSARS-CoV-2United StatesCannabidiolcannabidiolinnate immunityPMN

Identifiers

PMID36834537
PMCPMC9964491
OpenAlexW4319318157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.